• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»digital therapeutics

Merck KGaA just made a quiet digital-health move. Could hybrid drugs be pharma’s next big reset?

By Pallavi Madhiraju on April 29, 2026   Medical Devices & Diagnostics, Pharma & Biotech  

Merck KGaA just made a quiet digital-health move. Could hybrid drugs be pharma’s next big reset?

Digital therapeutics struggled alone. Remepy and Merck KGaA are testing whether software works better when built into the drug itself.

Why the Syra Health and Nora Mental Health deal matters for telebehavioral care in Indiana

By Pallavi Madhiraju on April 3, 2026   Pharma & Biotech  

Why the Syra Health and Nora Mental Health deal matters for telebehavioral care in Indiana

Syra Health and Nora Mental Health are linking AI triage with teletherapy in Indiana. Read why this could reshape digital mental health access.

How DarioHealth aims to strengthen oral GLP-1 effectiveness through precision behavioral health tools

By Pallavi Madhiraju on March 8, 2026   Pharma & Biotech  

How DarioHealth aims to strengthen oral GLP-1 effectiveness through precision behavioral health tools

DarioHealth targets oral GLP-1 therapy support with behavioral digital tools. Discover how digital health platforms could reshape obesity and diabetes treatment.

Can smart dental devices redefine sleep disorder treatment? Aesyra’s trial says yes

By Pallavi Madhiraju on January 26, 2026   Medical Devices & Diagnostics  

Can smart dental devices redefine sleep disorder treatment? Aesyra’s trial says yes

Aesyra’s AesyBite Active reduced sleep bruxism by over 60% in trial. Find out what this could mean for digital therapeutics and FDA approval in 2026.

Brello Rise enters the obesity care landscape as a digital wellness adjunct to medical weight loss

By Pallavi Madhiraju on January 26, 2026   Pharma & Biotech  

Brello Rise enters the obesity care landscape as a digital wellness adjunct to medical weight loss

Brello Health launches Brello Rise, a digital studio for patients in medical weight loss programs. Find out what this signals for obesity care models.

Recent Posts

  • Can Servier’s $2.65bn Edgewise deal reshape the muscular dystrophy drug race?
  • Can Convergent Therapeutics define the next prostate cancer standard after Lu-PSMA therapy?
  • Why T-CURX’s Pantherna acquisition could matter for the future of cell therapy manufacturing
  • Is Amgen’s bispecific lung cancer drug becoming a global standard after chemotherapy failure?
  • Fulgent Genetics’ oncology pivot gets sharper as FID-007 shows Phase 2 activity at ASCO 2026
  • Minghui and Qilu push MHB088C forward as prostate cancer ADC race tightens
  • Why Aphranel’s EU MDR approval could sharpen competition in CaHA dermal fillers
  • Oricell’s ASCO 2026 liver cancer data put GPC3 CAR-T back in the spotlight
  • Can Lilly turn Hanmi’s sonefpeglutide into the next long-acting GLP-2 rare disease bet?
  • Can enicepatide and petrelintide help Genentech build a differentiated obesity franchise?
  • Can Summit and Akeso turn ivonescimab into a global lung cancer challenger?
  • Why Tempus AI’s Lens upgrade matters for precision oncology drug development
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes